NEW YORK (GenomeWeb News) – Roche subsidiary 454 Life Sciences is collaborating with researchers at Cold Spring Harbor Laboratory to fight a mysterious disease afflicting one of Australia’s signature animals: the Tasmanian devil.
 
The CSHL project, led by Tasmanian native Elizabeth Murchison, a post-doctoral researcher, aims to understand the genetics of a fatal cancer ravaging wild Tasmanian devil populations. The team presented its research plan to visiting Tasmanian government officials last week.  
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.